de Groot Marcel J
Sandwich Chemistry, Pfizer Global Research & Development, Sandwich Laboratories, Kent CT13 9NJ, UK.
Drug Discov Today. 2006 Jul;11(13-14):601-6. doi: 10.1016/j.drudis.2006.05.001.
Many 3D ligand-based and structure-based computational approaches have been used to predict, and thus help explain, the metabolism catalyzed by the enzymes of the cytochrome P450 superfamily (P450s). P450s are responsible for >90% of the metabolism of all drugs, so the computational prediction of metabolism can help to design out drug-drug interactions in the early phases of the drug discovery process. Computational methodologies have focused on a few P450s that are directly involved in drug metabolism. The recently derived crystal structures for human P450s enable better 3D modelling of these important metabolizing enzymes. Models derived for P450s have evolved from simple comparisons of known substrates to more-elaborate experiments that require considerable computer power involving 3D overlaps and docking experiments. These models help to explain and, more importantly, predict the involvement of P450s in the metabolism of specific compounds and guide the drug-design process.
许多基于配体和基于结构的3D计算方法已被用于预测细胞色素P450超家族(P450s)酶催化的代谢过程,从而有助于解释该过程。P450s负责所有药物90%以上的代谢,因此代谢的计算预测有助于在药物发现过程的早期阶段设计出药物-药物相互作用。计算方法主要集中在少数直接参与药物代谢的P450s上。最近获得的人类P450s晶体结构能够对这些重要的代谢酶进行更好的3D建模。为P450s建立的模型已从已知底物的简单比较发展到需要大量计算机能力的更精细实验,包括3D重叠和对接实验。这些模型有助于解释,更重要的是预测P450s在特定化合物代谢中的作用,并指导药物设计过程。